ZOLADEX: payments to doctors
Payments that named ZOLADEX as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $703K
- Providers
- 5,106
- Transactions
- 10,601
- Average per transaction
- $66
The per-transaction average — $66 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,106 providers the average total is $138, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Tersera Therapeutics LLC | $699,957 | 99.6% |
| Astrazeneca UK Limited | $2,660 | 0.4% |